Receiving a breast cancer diagnosis can bring an immediate flood of questions, and for many patients, an overwhelming sense of urgency. Where do I start? Who do I call? What happens next? These are questions the team at Bedford Breast Center hears every day, and answering them clearly and without rushing is where the work begins.
From the very first appointment, the priority is ensuring that every patient has a guided path forward. Not a generic checklist, but a process shaped around her specific situation and what her diagnosis actually calls for.
While every case is different, there are several key areas the care team evaluates when working with a newly diagnosed patient. Understanding what to expect at each stage, and why it matters, can help bring a sense of order to what might otherwise feel like an uncertain and frightening time.
Genetic Testing
One of the first questions the team considers is whether a gene mutation may have contributed to the diagnosis, and whether other family members could benefit from that information.
Genetic testing is typically performed using a simple saliva sample, making it a straightforward part of the early evaluation process. Results are reviewed with the patient directly, with time set aside to answer questions and explain what the findings do and do not mean. The most commonly evaluated genes include BRCA1 and BRCA2, though panels today are broader and cover a range of mutations that may be relevant.
While genetic results do not change the overall prognosis, they can meaningfully influence surgical planning. Some patients with an identified gene mutation may choose a double mastectomy with reconstruction rather than breast-conserving surgery. Others may choose breast-conserving surgery, also known as a lumpectomy. The care team presents every option clearly and without pressure, because the right choice is the one the patient feels at peace with.
MRI Imaging
To plan the most precise and appropriate surgical approach, Bedford Breast Center’s team coordinates MRI imaging as a part of a patient’s care plan. Unlike mammography, MRI does not use radiation. It uses an intravenous dye to map breast tissue and the lymph node region, helping to determine the size of the area of concern and whether additional areas, in either breast, require attention.
Once results are available, the care team reviews and communicates findings directly, ensuring patients understand what the images reveal and what they mean for next steps.
Interpreting Biopsy Results
A biopsy provides a tissue sample that a pathologist examines to confirm whether cancer cells are present. Once cancer is identified, the pathologist performs additional analysis to understand the specific characteristics of those cells.
These characteristics include hormone receptor status, specifically whether the cancer cells respond to estrogen or progesterone, and whether a protein called the HER2 receptor is present. Some labs also measure a marker called Ki67, which provides insight into how actively the cells are dividing.
This information helps determine where the cancer falls on the spectrum of breast cancer activity and shapes decisions about treatment. In cases where receptor results fall into a less defined zone, additional assay testing, such as Oncotype or Mammoprint, may be ordered. These tests draw on outcomes data from patients with similar profiles to help guide decisions about whether chemotherapy is appropriate, and if so, when.
Some patients begin chemotherapy before surgery; others may not require it at all. For those who do, results from surgery often help determine the type and duration of treatment. Each plan is built around the individual.
Fertility Preservation
For patients who may wish to have biological children in the future, early consultation with a fertility specialist is an important consideration. Our team is happy to suggest some of our Fertility Specialist colleagues for you to meet with.
Devising Your Treatment Plan without Delay
Some patients prefer to meet with the care team quickly, before all results are in, simply to understand what general options look like and to feel less alone in the process. Bedford Breast Center can accommodate this at whatever pace feels right.
Other patients prefer to wait until genetic testing, MRI results, and biopsy findings are all available before discussing specific recommendations. For those patients, a follow-up appointment allows for a thorough, informed conversation about the most appropriate path forward, in the right order, without unnecessary delay.
Our approach is built around minimizing the wait between the time an area of concern is identified to completing all evaluations and exams. Fortunately, the time it takes to gather all necessary information has not been shown to impact treatment options or prognosis.
A Note on the Emotional Weight of This Moment
A breast cancer diagnosis is not just a clinical event. It carries emotional weight that the team at Bedford Breast Center takes seriously.
For patients experiencing significant anxiety during the information-gathering period, the clinical team is available to discuss supportive options, including anti-anxiety medication when appropriate. Additional resources through the Cancer Support Community and other adjunctive support programs are also available, and the team is glad to help patients connect with them.
The goal is not simply to treat a diagnosis. It is to guide each patient through one of the most significant experiences of her life with clarity, coordination, and care.
FAQs
1. How long do I have to wait before starting treatment? Will waiting hurt my chances?
This is one of the most common concerns we hear from newly diagnosed patients, and it is completely understandable. The period between diagnosis and treatment can feel agonizing, particularly when every instinct is telling you to act immediately.
The reassuring reality is that the time needed to gather complete information — genetic testing, MRI imaging, full biopsy analysis — has not been shown to negatively impact treatment outcomes or prognosis for the vast majority of breast cancers. Most breast cancers are not so fast-moving that a period of careful, thorough evaluation changes what is possible. What that window does change is the quality and precision of the treatment plan. Rushing into surgery before all results are in can mean making decisions with incomplete information, which sometimes leads to additional procedures later. At Bedford Breast Center, the goal is to move efficiently through the evaluation process so that when treatment begins, it begins with clarity and confidence.
2. Can I come to Bedford Breast Center for a second opinion?
Absolutely. A second opinion can confirm what you have already been told, surface additional treatment considerations, or simply give you the confidence that comes from knowing more than one experienced team has reviewed your case. Whatever the outcome, patients almost always leave feeling more grounded and more prepared to move forward.
If you are coming to us with a diagnosis in hand, our team will review your pathology, imaging, and any available test results thoroughly and without bias. We can also order additional imaging if deemed appropriate. We will tell you what we see, answer your questions honestly, and support whatever decision feels right for you, whether that means continuing care with us or returning to your original provider with greater peace of mind.
3. What is the difference between a lumpectomy and a mastectomy, and how do I know which is right for me?
A lumpectomy, sometimes called breast-conserving surgery, removes the tumor and a surrounding margin of healthy tissue while leaving the rest of the breast intact. A mastectomy removes the entire breast, and in some cases both breasts. Both are established surgical approaches, and for many patients, either option is medically appropriate.
The right choice depends on a number of factors, including the size and location of the tumor, whether the cancer is present in more than one area of the breast, the results of MRI imaging, and whether genetic testing has identified a mutation that increases the risk of future cancer. Personal preference also plays a meaningful role. Some patients feel strongly about preserving the breast; others feel more at peace knowing the tissue has been removed entirely. There is no universally correct answer. What matters is that the decision is made with full information, honest conversation, and without pressure. The care team at Bedford Breast Center is here to walk through every consideration so that patients feel confident in whatever path they choose.
4. If I test positive for a gene mutation, does that automatically mean my family members have it too?
A positive result in your own testing does not confirm anything about your relatives’ status, but it does open an important door. Knowing that a mutation runs in the family gives those relatives the opportunity to pursue their own genetic counseling and testing, and if needed, to take proactive steps to monitor or reduce their risk before a diagnosis ever occurs.
This is one of the reasons genetic testing is considered so early in the evaluation process at Bedford Breast Center. The results are not just meaningful for you. They can be genuinely life-changing information for the people you love. Our team can help guide you through how to approach those conversations with family members, and we are happy to point relatives in the right direction for their own testing and counseling when the time feels right.
5. What factors determine if I will need chemotherapy as a part of my treatment plan?
Several factors come into play when determining whether chemotherapy is appropriate, and the answer is different for every patient. The type of cancer, its stage, and its receptor status all provide important clues. A cancer that is hormone receptor-positive, for example, may respond well to hormone-blocking therapy alone, making chemotherapy unnecessary. A HER2-positive cancer, on the other hand, typically calls for targeted therapy in addition to other treatments.
Timing is also a consideration. Some patients receive chemotherapy before surgery to shrink a tumor and expand surgical options. Others receive it after. In either case, the decision is never made arbitrarily. At Bedford Breast Center, every recommendation is grounded in the specifics of your diagnosis and made with your full understanding and input.
Leave a Reply